School of Medicine
Showing 401-500 of 964 Results
-
Devin Malloy McCauley
Postdoctoral Scholar, Adolescent Medicine
BioDevin McCauley earned his PhD in Human Development and Family Studies from The Pennsylvania State University in 2021, where his research applied intensive longitudinal methods and time-varying effect modeling to investigate family, school, and peer influences on adolescent mental health and well-being. A second focus of his research applies a developmental framework in study of adolescent e-cigarette use. He is particularly interested in identifying sociodemographic (e.g., race/ethnicity, sexual identity) disparities in risk factors for e-cigarette use. His long-term goal is to inform, develop, and evaluate family and school-based prevention programs which support healthy adolescent development and address health disparities related to e-cigarette use.
-
Emily Clair McClung, MD, FACOG
Clinical Assistant Professor, Obstetrics & Gynecology - Gynecologic Oncology
BioDr. McClung is a fellowship trained, board certified Gynecologic Oncologist with the Stanford Medicine Cancer Center and Clinical Assistant Professor in the Stanford Medicine Department of Obstetrics and Gynecology, Division of Gynecologic Oncology.
She graduated from the Icahn School of Medicine at Mount Sinai in New York City and she completed residency in Obstetrics and Gynecology at Stanford Medicine. She then pursued sub-specialty Gynecologic Oncology fellowship at Moffitt Cancer Center and the University of South Florida in Tampa, Florida.
Prior to joining Stanford Health Care, Dr. McClung was an Assistant Professor in the Department of Obstetrics and Gynecology at the University of Arizona Banner University Medical Center in Tucson, Arizona.
Dr. McClung actively contributes to gynecologic cancer research. She has studied prevention of surgical site infections, gene expression prediction of lymph node metastasis in endometrial cancer, treatment resistance in ovarian cancer, and additional topics. She co-authored articles on her findings for peer-reviewed publications such as the International Journal of Gynecologic Cancer, International Journal of Women’s Health, and Gynecologic Oncology Reports.
She authored the chapter on the diagnosis and management of vaginal cancer in the textbook Handbook of Gynecology and has made invited presentations at meetings of the Society of Gynecologic Oncology and other associations. She works to improve patient access to state-of-the-art care as an investigator in cooperative group clinical trials.
She has won multiple teaching awards for her work with medical students and residents. She is passionate about increasing awareness of gynecologic cancer in medical trainees.
Dr. McClung provides comprehensive care with a personalized approach for patients with gynecologic cancer and pre-cancer including surgery, chemotherapy, cancer risk reduction, and palliative care. She has a strong clinical interest in patient safety and quality of life both during and after cancer treatment. -
Helena McCombie
Chief of Staff - Office of the Chair, Medicine
Current Role at StanfordChief of Staff - Office of the Chair at Stanford University School of Medicine Department of Medicine
-
Michael V. McConnell, MD, MSEE
Clinical Professor, Medicine - Cardiovascular Medicine
Current Research and Scholarly InterestsMy imaging research has involved clinical and molecular Imaging of cardiovascular disease, with a focus on coronary and vascular diseases, including atherosclerosis, aortic aneurysms, and vascular inflammation.
My prevention research has involved innovative technologies to reduce coronary and vascular disease, including early disease detection plus leveraging mobile health and AI to enhance heart heart in patients and populations. -
Jamie McDonald, MD, MS
Clinical Assistant Professor, Neurology & Neurological Sciences
BioDr. McDonald is a fellowship-trained, board-certified neurologist and clinical assistant professor in the Department of Neurology at Stanford University School of Medicine.
She specializes in the diagnosis and treatment of multiple sclerosis and other demyelinating diseases, including neuromyelitis optica spectrum disorder (NMOSD) and myelin oligodendrocyte glycoprotein antibody disease (MOGAD). Dr. McDonald also provides comprehensive care to general neurology patients.
Dr. McDonald completed her internship and adult neurology residency at the University of Utah. She has a long-standing interest in multiple sclerosis care and went on to complete a two-year clinical MS/neuroimmunology fellowship at Stanford Health Care Multiple Sclerosis Center. Dr. McDonald received the National MS Society’s Sylvia Lawry Physician Fellowship, including formalized training in conducting clinical trials. As part of her fellowship, she completed a master’s degree in epidemiology and clinical research. -
Sean McGhee
Clinical Associate Professor, Pediatrics - Immunology and Allergy
Current Research and Scholarly InterestsBioinformatics
-
LAWRENCE McGLYNN
Clinical Professor, Psychiatry and Behavioral Sciences - Medical Psychiatry
Current Research and Scholarly InterestsMethamphetamine Abuse
HIV Neuropsychiatry -
Mark McGovern
Professor of Psychiatry and Behavioral Sciences (Public Mental Health and Population Sciences)
BioDr. Mark McGovern is a Professor in the Department of Psychiatry & Behavioral Sciences and, by courtesy, the Department of Medicine at Stanford University School of Medicine.
Most people who need health care do not receive it. And of those who do, wide variation exists in the quality of the care they receive. Gaps in health care access and quality are worse for certain groups, such as underrepresented minorities and persons living in low-resourced urban and rural areas, and/or in poverty. Enormous disparities exist in health care systems, both private and public. Dr. McGovern is a leader in using rigorous methods of dissemination and implementation (D&I) science to close these gaps in equitable health care delivery.
His mission is to get the best health care possible to the people who need it the most.
Dr. McGovern's primary focus is the implementation and sustainment of evidence-based interventions and guideline adherent care in public and private health care systems and organizations. Within the hub of the Center for Dissemination and Implementation (CDI) which he directs, Dr. McGovern is the Principal Investigator (PI) and leads three national dissemination and implementation (D&I) centers: The Center for Dissemination and Implementation At Stanford (C-DIAS); The Research Adoption Support Center (RASC); and, the Mental Health Technology Transfer Center Network Coordinating Center (MHTTC). The 3 centers are federally-funded, respectively by the National Institute on Drug Abuse (P50DA05402), the National Institutes of Health Healing Addiction Long Term (HEAL) initiative (U2CDA057717), and the US Department of Health and Human Services Substance Use and Mental Health Services Administration (H79SM081726). Dr. McGovern is also the PI on a multi-site adaptive implementation trial across a state system of care, which aims to integrate addiction medications for persons with opioid use disorder who are receiving services in specialty or primary care organizations (R01DA052975). In addition, he conducts D&I research and practice projects in federally-qualified health centers (FQHCs) across the State of California, in the Stanford Division of Primary Care and Population Health, and in specialty addiction and mental health treatment organizations nationwide. He leads, facilitates and/or actively engages networks advancing D&I science in health, including the NIDA Clinical Trials Network Translation & Implementation Special Interest Group, the NIDA Clinical Trials Western States Node Translation & Implementation Workgroup, the Stanford University Network for Dissemination & Implementation Research (SUNDIR), the VA Palo Alto HSR&D Center for Innovation to Implementation, and the Stanford Medicine Center for Improvement. He is on the Core Faculty of the National Institute of Mental Health Implementation Research Institute at the Washington University in St. Louis. Dr. McGovern is a collaborator on multiple projects as a co-investigator, consultant, or advisory board member. He is a mentor to numerous individuals across the country and at Stanford, from university undergraduates to mid-career faculty and clinical administrators at academic institutions and health care systems nationwide. -
Joseph Cole McGrath
Child Psychiatry Research Coordinator, Psychiatry and Behavioral Sciences - Child & Adolescent Psychiatry and Child Development
BioJoseph McGrath graduated with honors from Stanford University with his B.S. in Human Biology, concentrating in neuroscience and psychopathology. Working with the Autism and Developmental Disorders Research Program (ADDRP), he currently coordinates the Autism Center of Excellence (ACE) Sleep Medication Clinical Trials. Additionally, Joseph works in the Preschool Autism Lab (PAL) as a registered behavior technician for children with autism. Interested in the interplay between psycho- and pharmacotherapies, Joseph plans to attend medical school, hoping his exploration will inform a future in clinical psychiatric research.
-
Steven Lee Mcintire
Clinical Associate Professor, Neurology & Neurological Sciences
BioDr. McIntire earned his MD from Harvard Medical School and his PhD in Neuroscience from Harvard University, where he was awarded a Frank Knox Memorial Fellowship and Carl Walter Fellowship. He then completed Neurology residency training at UCSF. He is board certified in Neurology by the American Board of Psychiatry and Neurology. He has been named a Robert Ebert Clinical Scholar and Culpepper Medical Science Scholar. Dr. McIntire has published extensively in the fields of molecular neurobiology and neurogenetics.
Dr. McIntire’s interests are in general/comprehensive neurology. He is also interested in medical education and the training of medical students and neurology residents. -
Abby McIntyre
Lead Clinical Research Coordinator, Orthopaedic Surgery
Current Role at StanfordClinical Research Coordinator Associate (to Dr. Emily Kraus) for the FASTR Program
-
David B. McKay
Professor of Structural Biology, Emeritus
Current Research and Scholarly InterestsThree-dimensional structure determination and biophysical studies of macromolecules.
-
Stephen Lawrence McKenna, MD
Clinical Professor (Affiliated), Neurosurgery
BioDr. Stephen McKenna is a founding member of the Stanford Partnership for Spinal Cord Injury and Repair. He is currently the Chief of the Rehabilitation Trauma Center; as well as, the site director of the Advanced SCI Medicine Fellowship at SCVMC.
As a Neurocritical Care physician, Dr. McKenna specializes in ventilator-dependent Spinal Cord and Traumatic Brain Injury, as well as neuromuscular diseases. He has led first-in-human clinical trials ranging from vaccines for HIV to stem cell-derived oligodendrocyte progenitor cell-based therapies for SCI. Dr. McKenna is Chairman of the Respiratory Section of the International Standards to Document Autonomic Function after SCI (ISAFSCI) and co-chair of the American Spinal Cord Injury Association (ASIA) Research Education Subcommittee.
Clinical Focus:
Spinal Cord Injury
Traumatic Brain Injury
Amyotrophic lateral sclerosis (ALS)
Guillain-Barre syndrome (GBS)
Anti-NMDA receptor encephalitis
Neuromyelitis Optica (Devic disease)
Professional Education:
Board Certification: Neurocritical Care, UCNS (2008)
Board Certification: Internal Medicine, ABIM (2005)
Internship & Residency: Santa Clara Valley Medical Center (2002,2005)
Medical Education: Stanford University School of Medicine (2002)
Book Chapter:
Shah A, Shem K, McKenna SL, Berlly M. Management of Respiratory Failure in Spinal Cord Injury. Spinal Cord Medicine (Hardcover) by Steven, M.D. Kirshblum (Editor) Lippincott Williams & Wilkins; 2011
Selected Publications:
Exploration of surgical blood pressure management & expected motor recovery in individuals with traumatic SCI.
Ehsanian R, et al, McKenna SL.
Spinal Cord. 2020 Mar;58(3):377-386. PMID: 31649323
A Novel Pharyngeal Clearance Maneuver for Initial Tracheostomy Tube Cuff Deflation in High Cervical Tetraplegia.
Ehsanian R, et al, McKenna S.
Am J Phys Med Rehabil. 2019 Sep;98(9):835-838. PMID: 30973517
Burden of Care Implications & Association of Intracranial Hypertension with Extremely Severe Post-traumatic Amnesia After TBI: A 5-Year Retrospective Longitudinal Study.
Quach NT, et al
Front Neurol. 2019 Jan 29;10:34. PMID: 30761071
Venous Thromboembolism is Associated with Lack of Vitamin D Supplementation in Patients with SCI & Low Vitamin D Levels.
Ehsanian R, et al
PM R. 2019 Feb;11(2):125-134. PMID: 30300766
Pulmonary outcomes following specialized respiratory management for acute cervical SCI: a retrospective analysis.
Zakrasek EC, et al, McKenna SL
Spinal Cord, 2017; Feb 21. PMID: 28220822
Dose Response Effect of Exposure to Hypotension on Expected Neurological Recovery in Individuals with Traumatic SCI.
ARCHIVES OF PM&R
Reza, E., et al, McKenna, S.
2016: DOI: http://dx.doi.org/10.1016/j.apmr.2016.09.016
Combined SCI & TBI: recovery of forelimb function after unilateral cervical SCI is retarded by contralateral traumatic brain injury (TBI), & ipsilateral TBI balances the effects of SCI on paw placement.
EXPERIMENTAL NEUROLOGY
Inoue T, et al.
2013 Oct 248: 136-47. PMID: 23770071
Functional electrical stimulation in SCI respiratory care.
TOPICS IN SPINAL CORD REHAB.
R Jarosz, et al, S McKenna
2012:Vol. 18, No. 4, 315-321. PMID: 23459661
Impact of mean arterial blood pressure during the first seven days post SCI.
TOPICS IN SPINAL CORD REHAB.
J Cohn, et al
2010: DOI: http://dx.doi.org/10.1310/sci1503-96
Successful Pregnancy & Delivery in a C1 ASIA A spinal cord injured Woman: The Role of Coordinated Care Between PM&R & Obstetrics Services: A Case Report.
PM&R
Lin C, et al
2010: DOI: http://dx.doi.org/10.1016/j.pmrj.2010.07.461
The impact of project closure on HIV incidence and mortality in a cohort of couples in Lusaka, Zambia.
AIDS CARE
Stephenson R, et al
2008 Jul;20(6):683-91. PMID: 18576170
Rapid HIV testing & counseling for voluntary testing centers in Africa.
AIDS
McKenna SL et al
1997 Sep;11 Suppl 1:S103-10. PMID: 9376093 -
Rebecca Mckenzie
Clinical Assistant Professor, Pediatrics - General Pediatrics
Current Research and Scholarly InterestsPediatric liver transplant, outcomes, adherence, transition, liver failure
-
Tracey McLaughlin
Professor of Medicine (Endocrinology)
Current Research and Scholarly InterestsDr. McLaughlin conducts clinical research related to obesity, insulin resistance, diabetes, and cardiovascular disease (CVD). Current studies include: 1) the impact of macronutrient composition on metabolism, DM2 and CVD; 2) comparison of different weight loss diets on metabolism and CVD risk reduction ; 3) role of adipocytes and adipose tissue immune cells in modulating insulin resistance; 4) use of continuous glucose monitoring and multi-omics to define metabolic phenotype and precision diets
-
Carmen McLean
Clinical Professor (Affiliated), Psych/General Psychiatry and Psychology (Adult)
BioCarmen McLean, PhD, is a clinical psychologist and researcher with the Dissemination and Training Division of the National Center for PTSD at the Palo Alto VA Health Care System. Dr. McLean’s research focuses on increasing the implementation and reach of evidence-based treatments for posttraumatic stress disorder (PTSD).
-
Uel Jackson McMahan
Professor of Neurobiology and of Structural Biology, Emeritus
Current Research and Scholarly InterestsWe are currently investigating mechanisms involved in synaptic transmission and synaptogenesis using electron microscope tomography in ways that provide in situ 3D structural information at macromolecular resolution.
-
Jennifer A McNab
Associate Professor (Research) of Radiology (Radiological Sciences Laboratory)
Current Research and Scholarly InterestsMy research is focused on developing magnetic resonance imaging (MRI) methods that probe brain tissue microstructure. This requires new MRI contrast mechanisms, strategic encoding and reconstruction schemes, physiological monitoring, brain tissue modeling and validation. Applications of these methods include neuronavigation, neurosurgical planning and the development of improved biomarkers for brain development, degeneration, disease and injury.
-
M Windy McNerney, PhD
Clinical Associate Professor (Affiliated), Psych/General Psychiatry and Psychology (Adult)
Staff, Psychiatry and Behavioral SciencesBioDr. M. Windy McNerney is the Director of Biological Sciences for the MIRECC at the Department of Veterans Affairs in Palo Alto, and a Clinical Associate Professor (Affiliated) at Psychiatry and Behavioral Sciences at Stanford School of Medicine. Dr. McNerney holds a particular passion for not only understanding the neurophysiology and biochemistry of mental health diseases, but also advocating for these invisible diseases. Her research focuses on neurodegeneration, depression, TBI, PTSD, and addiction. She is collaborating with researchers to integrate brain imaging and biochemical markers in hopes to better understand these diseases. She also is taking a lead role at the VA in investigating the biochemistry of magnetic brain stimulation and is the leader of the NeuroNado Laboratory. At Stanford University, she is the professor of two popular courses examining the biological and societal issues surrounding substance use disorder, with a major focus on opioids such as fentanyl. She has individually mentored over 25 students from underrepresented groups in STEM activities and leads monthly seminars aimed at facilitating career development. In her free time, she is a community advocate for the treatment of mental health and educates groups about the dangers of fentanyl.
She earned her BS from UC Davis and her PhD from the University of Notre Dame. While at ND, she interned at NASA Ames on Human Factors Engineering. She then went on to a postdoctoral position at Lawrence Livermore National Laboratory (DOE), and then completed a fellowship at the WRIISC program at the VA and Stanford University.
Selected Publications:
McNerney MW, Gurkoff G, Berryhill M (2023). The rehabilitation potential of neurostimulation for mild traumatic brain injury in animal and human studies. Brain Sciences, 13, 1402.
McNerney MW, Kraybill EP Narayanan S, Mojabi F, Venkataramanan V, Heath A (2023). Memory-related hippocampal brain-derived neurotrophic factor activation pathways from repetitive transcranial magnetic stimulation in the 3xTg-AD mouse line. Experimental Gerontology, 183, 11323.
Shuken, S, McNerney MW (2023). Cost and benefits for popular p-value correction methods I three models of quantitative omic experiments. Analytical Chemistry, 95, 2732.
McNerney MW, Heath A, Narayanan S, Yesavage J (2022). Repetitive transcranial magnetic stimulation improves brain-derived neurotrophic factor and cholinergic signaling in the 3xTgAD mouse model of Alzheimer’s disease. Journal of Alzheimer’s Disease, 86, 499..
Heath AM, Brewer M, Yesavage J, McNerney MW. (2021). Improved object recognition memory using post-encoding repetitive transcranial magnetic stimulation. Brain Stimulation, 15, 78.
Yang AC, Vest RT, Kern F, Lee DP, Agam M, Maat CA, Losada PM, Chen MB, Schaum N, Khoury N, Toland A, Calcuttawala K, Shin H, Palovics R, Shin A, Wang EY, Luo J, Gate D, Schultz-Schaeffer WJ, Chu P, Siegenthalar J, McNerney MW, Keller A, Wyss-Coray T (2022). A human brain vascular atlas reveals diverse mediators or Alzheimer’s disease. Nature, 603, 885.
McNerney MW, Hobday T, Cole B, Ganong R, Winas N, Matthews D, Hood J, Lane S (2019). Objective classification of mTBI using machine learning on a combination of frontal electroencephalography measurements and self-reported symptoms. Sports Medicine Open, 4, 14.
McNerney MW, Sheng T, Nechvatal JM, Lee A, Lyons D, Adamson M (2018). Integration of neural and epigenetic contributions to posttraumatic stress symptoms: The role of hippocampal volume and glucocorticoid receptor gene methylation. PLOSONE, e0192222.
Bennion BJ, Be NA, McNerney MW, Lao V, Carlson E, Valdez CA (2017). Predicting a drug’s membrane permeability: A computational model validated with in vitro permeability assay data. Journal of Physical Chemistry, B, 121, 5228.
See more publications at: https://www.ncbi.nlm.nih.gov/pubmed/?term=McNerney%20MW%5BAuthor%5D&cauthor=true&cauthor_uid=17107728 -
Kimford Meador, MD
Professor of Neurology (Adult Neurology)
BioDr. Meador is a Professor of Neurology and Neurosciences at Stanford University, and Clinical Director, Stanford Comprehensive Epilepsy Center. Dr. Meador graduated from the Georgia Institute of Technology in Applied Biology (with high honor) and received his MD from the Medical College of Georgia. After an internship at the University of Virginia and service as an officer in the Public Health Corps, he completed a residency in Neurology at the Medical College of Georgia and a fellowship in Behavioral Neurology at the University of Florida. Dr. Meador joined the faculty at the Medical College of Georgia (1984-2002) where he became the Charbonnier Professor of Neurology. He was the Chair of Neurology at Georgetown University (2002-2004), the Melvin Greer Professor of Neurology and Neuroscience at the University of Florida (2004-2008) where he served as Director of Epilepsy Program and Director of the Clinical Alzheimer Research Program, and Professor of Neurology and Pediatrics at Emory University (2008-2013) where he served as Director of Epilepsy and of Clinical Neurocience Research. He joined the faculty of Stanford University in 2013. Dr. Meador has authored over 400 peer-reviewed publications. His research interests include: cognitive mechanisms (e.g., memory and attention); cerebral lateralization; pharmacology and physiology of cognition; mechanisms of perception, consciousness and memory; EEG; epilepsy; epilepsy and pregnancy; preoperative evaluation for epilepsy surgery; intracarotid amobarbital procedure (i.e., Wada test); functional imaging; therapeutic drug trials; neurodevelopmental effects of antiepileptic drugs; psychoimmunology; behavioral disorders (e.g., aphasia, neglect, dementia); and neuropsychiatric disorders. Dr. Meador has served as the PI for a long running NIH multicenter study of pregnancy outcomes in women with epilepsy and their children. Dr. Meador has served on the editorial boards for Clinical Neurophysiology, Epilepsy and Behavior, Epilepsy Currents, Journal of Clinical Neurophysiology, Neurology, Cognitive and Behavioral Neurology, and Epilepsy.com. His honors include Resident Teaching Award Medical College of Georgia; Outstanding Young Faculty Award in Clinical Sciences Medical College of Georgia; Distinguished Faculty Award for Clinical Research Medical College of Georgia Lawrence C. McHenry History Award American Academy of Neurology; Dreifuss Abstract Award American Epilepsy Society; Fellow of the American Neurological Association; Diplomat of American Neurologic Association; past Chair of the Section of Behavioral Neurology of American Academy of Neurology; past President of Society for Cognitive and Behavioral Neurology; past President of the Society for Behavioral & Cognitive Neurology; past President of the Southern EEG & Epilepsy Society; ranking in the top 10 experts in epilepsy worldwide by Expertscape; Distinguished Alumnus Award for Professional Achievement, Medical College of Georgia, Georgia Regents University 2015; American Epilepsy Society Clinical Research Award; and named award by the American Epilepsy Society: “Kimford J. Meador Research in Women with Epilepsy Award,” and ranked in the top 500 neuroscientist in the world and top 300 in USA by Research.com in 2022.
-
Peter Meaney
Clinical Professor, Pediatrics - Critical Care
Current Research and Scholarly InterestsDr. Meaney is a nationally and internationally recognized pediatric resuscitation scientist, and his current focus is on improving care for seriously ill children at the community clinic and district hospital level in low and middle income countries. Dr Meaney seeks to conduct the necessary research to pioneer, implement and evaluate innovative yet relevant and practical solutions to improve the quality of care for seriously ill or injured children worldwide.
-
Bruno Medeiros
Adjunct Clinical Associate Professor, Medicine - Hematology
Current Research and Scholarly InterestsMy clinical activities combine the development of novel therapeutic modalities, translational research activities and epidemiological study of acute leukemia. My special focus is on the development of better, patient tailored therapies for young and elderly patients with acute leukemia.
-
Rishi Mediratta
Clinical Associate Professor, Pediatrics
Current Research and Scholarly InterestsI have developed a new promising neonatal mortality prediction score at the University of Gondar Neonatal Intensive Care Unit (NICU) in Gondar, Ethiopia. The score predicts approximately 84% of neonatal deaths in the NICU using clinical variables. I have a dataset over 800 NICU admissions in Gondar. I am recruiting scholars who are interested in conducting clinical and epidemiological research to validate, refine, and implement the mortality score to reduce neonatal mortality in Ethiopia.
-
Natalia Medvedeva
Clinical Assistant Professor, Medicine - Infectious Diseases
BioDr Natalia Medvedeva specializes in the treatment of infectious diseases. She has a special interest in antimicrobial stewardship and medical education.
-
Jessica Lee Mega
Affiliate, Medicine - Med/Cardiovascular Medicine
BioJessica L. Mega, MD, MPH is a leader at the intersection of technology, life science, and health care. She is a Cardiologist at Stanford and serves on the Advisory Board for Stanford's Center for Digital Health. She is a Co-Founder of Alphabet's Verily, and she is on the Board of Directors at Boston Scientific and Danaher Corporation, as well as the Board of Advisors for Research!America and the Duke-Margolis Center for Health Policy.
As a faculty member at Harvard Medical School, a Senior Investigator with the TIMI Study Group, and a Cardiologist at Brigham and Women’s Hospital, Dr. Mega led large, international, randomized trials evaluating novel therapies. She also directed the TIMI Study Group’s Genomics Program, demonstrating and testing the role of CYP2C19 genetic variants on antiplatelet medications, a key pharmacogenetic finding. She has published manuscripts in the New England Journal of Medicine, Lancet, and JAMA. She served as an Advisor for the California Governor’s Precision Medicine Initiative.
Dr. Mega is a graduate of Stanford University, Yale University School of Medicine, and Harvard School of Public Health. She completed Internal Medicine Residency at Brigham and Women’s Hospital and Cardiovascular Fellowship at Massachusetts General Hospital. She is board certified in Internal Medicine and Cardiology. She has won the Laennec Society, Samuel A. Levine, and Douglas P. Zipes Awards, and she is a Fellow of the American Heart Association (AHA) and the American College of Cardiology (ACC). -
Uchechukwu Megwalu, MD, MPH
Professor of Otolaryngology - Head & Neck Surgery (OHNS)
Current Research and Scholarly InterestsOutcomes Research
Health Disparities
Comparative Effectiveness Research
Health Literacy
Head and Neck Cancer Epidemiology
SEER database analysis